ABCL
AbCellera Biologics Inc. Common Shares
stockNASDAQ
Market OpenNov 11, 2026 2:17:50 PM EST
12.16USD-2.408%(-0.30)1,722,611
Pre-marketNov 11, 2026 9:28:30 AM EST
12.64USD+1.445%(+0.18)
ABCL Financials
In Q3 FY 2026 (ended ), AbCellera Biologics Inc. Common Shares (ABCL) reported revenue of $10.64M, net income of −$40.76M, operating cash flow of $26.91M, and assets of $1.5B (filed ).
Loading financial statements…